10x the mRNA Production with Membrane Chromatography

This interview features: Jin Zhou, Co-Founder, Business Leader, Purilogics By Donaldson, from BioProcess International 2023.

Jin Zhou, co-founder, and business leader at Purilogics by Donaldson, discusses the company's mission and innovative solutions in an interview with Brandy Fidler at Biotech Boston. Purilogics aims to revolutionize biologics purification, addressing the industry's need for effective solutions. With a focus on membrane chromatography products, Purilogics offers fast and efficient purification for various biologics, including monoclonal antibodies, plasma proteins, mRNA, and plasmid DNA.

Purexa™ OdT, a proprietary membrane with oligo-deoxythymidine ligands, stands out for its fast purification and high binding capacity compared to other mRNA purification solutions. Its benefits include reduced processing time and decreased risk of degradation, making it ideal for unstable molecules like mRNA. Additionally, Purexa™ OdT streamlines biomanufacturing processes, reducing backlogs, and enhancing competitiveness.

The interview also touches on the Purilogics product range, including multi-well plate OdT products, syringe filter-like columns, and cassette-based devices, catering to various purification needs. With Donaldson's expertise in membrane technology, Purilogics has accelerated its commercialization and diversified its offerings.

As part of Donaldson's broader science organization, Purilogics leverages Donaldson's resources to scale up and commercialize its products effectively. Collaborations with other Donaldson acquisitions enable Purilogics to provide comprehensive solutions for the biopharmaceutical industry.

Overall, Purilogics by Donaldson is poised to drive innovation and efficiency in biologics purification, offering tailored solutions to meet industry demands.